Authors' Reply to Rangwala et al: "Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis"

Am J Cardiovasc Drugs. 2024 May;24(3):467-468. doi: 10.1007/s40256-024-00645-5. Epub 2024 Apr 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aspirin* / therapeutic use
  • Cardiovascular Diseases* / prevention & control
  • Humans
  • Meta-Analysis as Topic
  • Platelet Aggregation Inhibitors / therapeutic use
  • Primary Prevention* / methods
  • Renal Insufficiency, Chronic* / complications
  • Renal Insufficiency, Chronic* / drug therapy